RO-7239958

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameRO-7239958
Drug Alias NameRO-7239958RG-6217
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionTerminal nucleotidyltransferase 4B inhibitorsTerminal nucleotidyltransferase 4A inhibitors
TargetsTerminal nucleotidyltransferase 4BTerminal nucleotidyltransferase 4A
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche R&D Center (China) Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A